Hodgkin's lymphoma and Cellulitis
Summary:
Cellulitis is found among people with Hodgkin's lymphoma, especially for people who are male, 60+ old.
The study analyzes which people have Cellulitis with Hodgkin's lymphoma. It is created by eHealthMe based on reports of 34 people who have Hodgkin's lymphoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Hodgkin's lymphoma?
Hodgkin's lymphoma (cancer originating from white blood cells) is found to be associated with 416 drugs and 662 conditions by eHealthMe. Check the latest studies of Hodgkin's lymphoma.
What is Cellulitis?
Cellulitis (infection under the skin) is found to be associated with 2,080 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.
34 people who have Hodgkin'S Lymphoma and Cellulitis are studied.

Gender of people who have Hodgkin'S Lymphoma and experienced Cellulitis *:
- female: 31.03 %
- male: 68.97 %
Age of people who have Hodgkin'S Lymphoma and experienced Cellulitis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 12.5 %
- 20-29: 4.17 %
- 30-39: 4.17 %
- 40-49: 8.33 %
- 50-59: 33.33 %
- 60+: 37.5 %
Common co-existing conditions for these people *:
- Stress And Anxiety: 9 people, 26.47%
- Pain: 8 people, 23.53%
- Insomnia (sleeplessness): 8 people, 23.53%
- High Blood Pressure: 6 people, 17.65%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 5 people, 14.71%
- Dyslipidaemia (abnormal amount of lipids): 5 people, 14.71%
- Rashes (redness): 3 people, 8.82%
- Hyperglycemia (high blood sugar): 2 people, 5.88%
- Constipation: 2 people, 5.88%
- Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 2.94%
Common drugs taken by these people *:
- Bactrim: 9 people, 26.47%
- Amlodipine: 8 people, 23.53%
- Paracetamol: 8 people, 23.53%
- Dexlansoprazole: 5 people, 14.71%
- Apixaban: 5 people, 14.71%
- Dacarbazine: 5 people, 14.71%
- Adcetris: 4 people, 11.76%
- Oxycodone: 2 people, 5.88%
- Lenalidomide: 2 people, 5.88%
- Flexeril: 2 people, 5.88%
Common symptoms for these people *:
- Septic Shock (shock due to blood infection): 13 people, 38.24%
- Fatigue (feeling of tiredness): 11 people, 32.35%
- Pneumonia: 11 people, 32.35%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 29.41%
- Alanine Aminotransferase Increased: 10 people, 29.41%
- Aspartate Aminotransferase Increased: 10 people, 29.41%
- Thrombocytopenia (decrease of platelets in blood): 10 people, 29.41%
- Neuropathy Peripheral (surface nerve damage): 9 people, 26.47%
- High Blood Pressure: 9 people, 26.47%
- Muscle Aches (muscle pain): 8 people, 23.53%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Cellulitis?
- Check whether Cellulitis is associated with a drug or a conditionRelated publications that referenced our studies
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Related studies:
Treatments, associated drugs and conditions:
- Hodgkin's lymphoma (18,581 reports)
- Cellulitis (75,290 reports)
All the drugs that are associated with Cellulitis:
- Cellulitis (2,080 drugs)
All the conditions that are associated with Cellulitis:
- Cellulitis (2,338 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Cellulitis and Hodgkin's lymphoma, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Provera vs. Beyaz, side effect and effectiveness comparison - 21 seconds ago
- Levocetirizine Dihydrochloride vs. Clemastine Fumarate, side effect and effectiveness comparison - 25 seconds ago
- Diabetes and Thrombotic Thrombocytopenic Purpura - a minute ago
- Could Lyrica cause Myopathy Aggravated? - a minute ago
- Could Nucala cause Crohn'S Disease? - a minute ago
- Cataplexy and Meningioma - a minute ago
- Drug interactions of Pomalyst and Imbruvica - a minute ago
- Could Epzicom cause The Flu? - a minute ago
- Could Radicava cause Insomnia? - 2 minutes ago
- Could Azithromycin cause Gastrointestinal Bacterial Infection? - 2 minutes ago